Bioservo Technologies AB (publ)

OM:BIOS Rapport sur les actions

Capitalisation boursière : SEK 1.4m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Bioservo Technologies Croissance future

Future contrôle des critères 2/6

Bioservo Technologies is forecast to grow revenue at 69.3% per annum.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Medical Equipment croissance des bénéfices27.0%
Taux de croissance des recettes69.3%
Rendement futur des capitaux propres6.4%
Couverture par les analystes

Low

Dernière mise à jour08 Nov 2023

Mises à jour récentes de la croissance future

Recent updates

Is Bioservo Technologies (STO:BIOS) In A Good Position To Deliver On Growth Plans?

Sep 01
Is Bioservo Technologies (STO:BIOS) In A Good Position To Deliver On Growth Plans?

Bioservo Technologies (STO:BIOS) Is In A Good Position To Deliver On Growth Plans

Apr 11
Bioservo Technologies (STO:BIOS) Is In A Good Position To Deliver On Growth Plans

We're Not Very Worried About Bioservo Technologies' (STO:BIOS) Cash Burn Rate

Dec 27
We're Not Very Worried About Bioservo Technologies' (STO:BIOS) Cash Burn Rate

Prévisions de croissance des bénéfices et des revenus

OM:BIOS - Estimations futures des analystes et données financières antérieures (SEK Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/202558N/A261
12/31/202432N/A-15-131
12/31/202315N/A-39-381
9/30/202312-47-52-51N/A
6/30/202311-48-51-51N/A
3/31/202315-48-52-51N/A
12/31/202214-50-52-51N/A
9/30/202215-43-48-46N/A
6/30/202217-39-40-38N/A
3/31/202213-38-41-39N/A
12/31/202111-35-36-34N/A
9/30/20217-34-30-29N/A
6/30/20215-34-24-23N/A
3/31/202110-28-19-18N/A
12/31/202014-26-18-17N/A
9/30/202022-25-26-25N/A
6/30/202023-24-24-23N/A
3/31/202025-25-25-24N/A
12/31/201924-23-27-26N/A
9/30/201923-27-22-21N/A
6/30/201921-28-32-29N/A
3/31/201917-27-22-19N/A
12/31/201816-28-22-17N/A
9/30/201815-23-22-17N/A
6/30/201814-21-18-13N/A
3/31/201812-22-29-23N/A
12/31/201712-19-22-16N/A
9/30/201711-17-21-15N/A
6/30/201711-16N/A-14N/A
3/31/201712-12N/A-9N/A
12/31/201611-13N/A-13N/A
12/31/201511-7N/AN/AN/A
12/31/20148-4N/AN/AN/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if BIOS's forecast earnings growth is above the savings rate (0.8%).

Bénéfices vs marché: Insufficient data to determine if BIOS's earnings are forecast to grow faster than the Swedish market

Croissance élevée des bénéfices: Insufficient data to determine if BIOS's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: BIOS's revenue (69.3% per year) is forecast to grow faster than the Swedish market (1.4% per year).

Croissance élevée des revenus: BIOS's revenue (69.3% per year) is forecast to grow faster than 20% per year.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: BIOS's Return on Equity is forecast to be low in 3 years time (6.4%).


Découvrir les entreprises en croissance